Actively Recruiting
MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry
Led by Prof. Dr. med. Ingo Eitel · Updated on 2025-02-03
2000
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.
CONDITIONS
Official Title
MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is going to be treated with Myval THV
- Age 2518 years
- Ability to give informed consent
You will not qualify if you...
- Pregnant and lactating women
- Patients with hypersensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum, or any contrast media
- Patients in whom anti-platelet and/or anticoagulant therapy are contra-indicated
- Any condition which, in the Investigator's opinion, would preclude safe participation of patient in the registry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Lübeck, Schleswig-Holstein, Germany, 23538
Actively Recruiting
Research Team
I
Ingo Eitel, Prof. Dr.
CONTACT
C
Christian Frerker, PD Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here